Vaxart, Inc. (VXRT) › Cash & EquivalentsVaxart, Inc. (VXRT) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2008: $106.44M2009: $59.51M2010: $53.56M2011: $94.31M2012: $53.80M2013: $66.80M2014: $81.70M2015: $44.70M2016: $8.40M2017: $1.57M2018: $11.51M2021: $143.75M2022: $44.01M2023: $34.76M$34.76M2008Cash & Equivalents (USD)2023Fiscal YearCash & EquivalentsChange YoY2023$34.76M-21.0%2022$44.01M-69.4%2021$143.75M—2018$11.51M+632.4%2017$1.57M-81.3%2016$8.40M-81.2%2015$44.70M-45.3%2014$81.70M+22.3%2013$66.80M+24.2%2012$53.80M-43.0%2011$94.31M+76.1%2010$53.56M-10.0%2009$59.51M-44.1%2008$106.44M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share